Download To Publications - Provincial Laboratory for Public Health

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
National Centre for Streptococcus
Bibliography January 1, 1994 – May 31, 2005
55. Sikora, C., J. Speilman, K. Macdonald, G.J. Tyrrell and J.M. Embil. 2005. Necrotizing
fasciitis resulting from human bites: A report of two cases of disease caused by Group A
streptococci. Canadian Journal of Infectious Diseases. ACCEPTED.
54. Burnham, C.A., S. E. Shokoples and G.J. Tyrrell. 2005. Phosphoglycerate Kinase Inhibits
Epithelial Cell Invasion by Group B Streptococci. Microbial Pathogenesis. IN PRESS
53. Shariatzadeh, M., J.Q. Huang, G.J. Tyrrell, M.M. Johnson and T.J. Marrie. 2005. Bacteremic
pneumococcal pneumonia: A prospective study in Edmonton and municipalities. Medicine;
84:147-161.
52. Vanderkooi, O.G., D.E. Low, K. Green, J.E. Powis, A. McGeer and the Toronto Invasive
Bacterial Disease Network (member of the network). 2005. Predicting antimicrobial
resistance in invasive pneumococcal infections. Clinical Infectious Diseases;40:1288-1297.
51. Tyrrell, G.T., M. Lovgren, B. Kress and K. Grimsrud. 2005. Varicella-associated invasive
Group A streptococcal disease in Alberta, Canada – 2000-2002. Clinical Infectious
Diseases; 40:1055-1057.
50. Tyrrell, G.T., M. Lovgren, B. Kress and K. Grimsrud. 2005. Invasive Group A streptococcal
disease in Alberta, Canada-2000-2002. Journal of Clinical Microbiology; 43: 1678-1683.
49. Lopardo, H., P. Vidal, M. Sparo, P.Jeric, D. Centron, R. Facklam, H. Paganini, N. Pagniez,
M. Lovgren, B.Beall and the Argentinian Streptococcus Study group. 2005. Six-month
multicentre study on invasive infections due to Streptococcus pyogenes and Streptococcus
dysgalactiae subsp. equisimilis in Argentina. Journal of Clinical Microbiology; 43:802-807.
48. Facklam, R.R., M. Lovgren, P.L. Shewmaker and G.J. Tyrrell. 2003. Phenotypic description
and antimicrobial susceptibilities of Aerococcus sanguicola isolated from human clinical
samples. Journal of Clinical Microbiology; 41:2587-2592
47. Allen, U.D., S. Thomas, J. Carapetis, S. Henry, S. Wasfy, M. Lovgren, S. Richardson and
D.E. Low. 2003. Serotypes of respiratory tract isolates of Streptococcus pneumoniae from
Jamaican Children. International Journal of Infectious Disease;7:29-35.
46. Smith, A., A. Li, O. Tolomeo, G.J. Tyrrell, F. Jamieson and D. Fisman. 2003. Mass antibiotic
treatment for Group A streptococcus in two-long term care facilities. Emerging Infectious
Diseases, 9:1260-1265.
45. Vanderkooi, O.G., J.D. Kellner, A.W. Wade, T. Jadavji, J.P. Midgley, T. Louie and G.J.
Tyrrell. 2003. Invasive Streptococcus pneumoniae infection causing haemolytic uremic
syndrome in children: two recent cases. Canadian Journal of Infectious Diseases. 14:339343.
page 1 of 6
44. Tyrrell, G.J., M. Lovgren, B. Forwick, N.P. Hoe, J.M. Musser, and J.A. Talbot. 2002. M
types of group A streptococcal isolates submitted to the National Centre for Streptococcus
(Canada) from 1993 to 1999. Journal of Clinical Microbiology;40:4466-4471.
43. Tyrrell, G. J., A. Kennedy, S.E. Shokopoles and R.K. Sherburne. 2002. Binding and invasion
of HeLa and MRC-5 cells by Streptococcus agalactiae. Microbiology;148:3921-393.
42. Tyrrell, G.J., L. Turnbull, L.M. Teixeira, J. Lefebvre, M. Carvalho, R.R. Facklam and M.
Lovgren. 2002. Enterococcus gilvus sp. nov., and Enterococcus pallens sp. nov., isolated
from human clinical specimens. Journal of Clinical Microbiology;40:1140-1145.
41. Facklam, R.F., D.R. Martin, M. Lovgren, D.J. Johnson, A. Efstratiou, T.A. Thompson, S.
Gowan, P. Kriz, G.J. Tyrrell, E. Kaplan and B. Beall. 2002. Extension of the Lancefield
classification for group A streptococci by addition of 22 new M protein gene sequence types
from clinical isolates: emm103 to emm124. Clinical Infectious Diseases;34:28-38.
40. Scheifele, D. S. Halperin, L. Pelletier, J. Talbot, M. Lovgren, W. Vaudry, T. Jadavji, B. Law,
N. MacDonald, R. Gold, E. Wang, E. Mills, M. Lebel, P. Dery, and R. Morris. 2001.
Reduced susceptibility to penicillin among pneumococci causing invasive infection in
children - Canada, 1991 to 1998. Canadian Journal of Infectious Disease;12:241-246.
39. Di Fabio, J.L., E. Castañeda, C. I. Agudelo, F. de la Hoz, M. Hortal, T. Camou, G. EchanizAviles, M. Barajas, I. Heitmann, J. Hormazabal, M. Brandileone, V. Simonsen, M.
Regueira, R. Ruvinski, A. Corso, M. Lovgren, J. Talbot, C. de Quadros and the PAHO
SIREVA-Vigia Study groups. 2001. Evolution of Streptococcus pneumoniae serotypes and
penicillin susceptibility in Latin America, Sireva-Vigia Group-1993-1999. Pediatric
Infectious Diseases Journal;20:959-967.
38. Hortal, M., M. Lovgren, F. de la Hoz, C. I. Agudelo, M. Brandileone, T. Camou, S.
Casagrande, E. Castañeda, A. Corso, G. Echaniz-Aviles, J. Hormazabal, J. Pace, R. Palacio,
G. Perez-Giffoni, R. Ruvinsky, J.L. di Fabio and the PAHO SIREVA-Vigia Study groups.
2001. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries:
biological and therapeutic implications. Microbial Drug Resistance 7:391-401.
37. Purcell, L., J.P. Finley, R. Chen, M. Lovgren, and S.A. Halperin. Gemella species
endocarditis in a child. 2001. Canadian Journal of Infectious Disease;12:317-320.
36. Kuhn, S.M., J. Preiksaitis, G.J. Tyrrell, T. Jadavji, D. Church and H.D. Davies. 2001.
Evaluation of potential factors contributing to microbiological treatment failure in
Streptococcus pyogenes pharyngitis. Canadian Journal of Infectious Disease;12:33-39
35. Barrington, K.J., P.C. Etches, R. Schulz, J.A.Talbot, A.J.Graham, R.J.Pearson and
P.Y.Cheung. 2000. The hemodynamic effects of inhaled nitric oxide and endogenous nitric
oxide synthesis blockade in newborn piglets during infusion of heat-killed group B
streptococci. Critical Care Medicine;28:800-808.
page 2 of 6
34. Beall, B., G. Gherardi, M. Lovgren, R.R. Facklam B. Forwick and G. J. Tyrrell. 2000. emm
and sof gene sequence variation in relation to serological typing of opacity-factor-positive
group A streptococci. Microbiology;146:1195-1209.
33. Goh, S.W., R.R. Facklam, M. Chang, J.E. Hill, G.J. Tyrrell, E.C.M. Burns, D. Chan, C. He,
T. Rahim, C. Shaw and S.M. Hemmingsen. 2000. Identification of Enterococcus species and
phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard
hybridization to chaperonin 60 gene sequences. Journal of Clinical Microbiology;38:39533959.
32. Scheifele, D., S. Halperin, L. Pelletier, J. Talbot and members of the Canadian Paediatric
Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active
(IMPACT). 2000. Invasive pneumococcal infections in Canadian children, 1991-1998:
implications for new vaccination strategies. Clinical Infectious Diseases 31:58-64.
31. Tyrrell, G.J., L.D. Senzilet, J.S. Spika, D.A. Kertesz, M. Alagaratnam, M. Lovgren, J.A.
Talbot and the Sentinel Health Unit Surveillance System Site Coordinators. 2000. Invasive
disease due to group B streptococcal infections in adults: results from a Canadian,
population-based, active laboratory surveillance study-1996. Journal of Infectious
Diseases;182:168-173.
30. Beall, B., G. Gherardi, B. Forwick, Z. Li, M. Lovgren, R. Facklam and G. J. Tyrrell. 2000.
Group A streptococcal emm and sof sequences correlated to M and anti-opacity factor types.
In Streptococci and streptococcal diseases entering the new millennium; proceedings of the
XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases.
Auckland, New Zealand.
29. Efstratiou, A., R.R. Facklam, E.L. Kaplan, P. Kriz, M. Lovgren, A. Totolian, B. Beall, D.
Johnson, R.C. George, S. Gowan, G. Tyrrell and D. Martin. 2000. Report of an international
quality assurance programme for group A streptococcal characterization. In Streptococci
and streptococcal diseases entering the new millennium; proceedings of the XIV Lancefield
International Symposium on Streptococci and Streptococcal Diseases. Auckland, New
Zealand.
28. Facklam R., B. Beall, A. Efstratiou, P. Kriz, G. Tyrrell, M. Lovgren, D. Martin and E.
Kaplan. 2000. Nomenclature of new emm types of group A streptococci. In Streptococci and
streptococcal diseases entering the new millennium; proceedings of the XIV Lancefield
International Symposium on Streptococci and Streptococcal Diseases. Auckland, New
Zealand.
27. Davies T., R.V. Goering, M. Lovgren, J.A. Talbot, M.R. Jacobs, and P. C. Applebaum. 1999.
Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from
Asia, Europe, and North America. Diagnostic Microbiology and Infectious Disease;34:7-12.
26. Facklam R. , B. Beall, A. Efstratiou, V. Fischetti, D. Johnson, E. Kaplan, P. Kriz, M.
Lovgren, D. Martin, B. Schwartz, A. Totolian, D. Bessen, S. Hollinshead, F. Rubin, J. Scott
and G. Tyrrell. 1999. emm typing and validation of provisional M types for group A
streptococci. Emerging Infectious Disease;5:247-253.
page 3 of 6
25. Kaul, R., A. McGeer, A. Norrby-Teglund, M. Kotb, B. Schwartz, K. O’Rourke, J. Talbot,
D.E. Low, and the Canadian Streptococcal Study Group. 1999. Intravenous immunoglobulin
therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin.
Infect. Dis. 28:800-807.
24. Louie, M., L. Louie, G. Papia, J. Talbot, M. Lovgren, and A.E. Simor. 1999. Molecular
analysis of the genetic variation among penicillin-susceptible and penicillin-resistant
Streptococcus pneumoniae serotypes in Canadian Journal of Infectious Disease;179:892900.
23. Spika, J.S., D. Kertesz, S. Deeks and J.A. Talbot. 1999. Pneumococcal immunization and
public health: the Canadian experience. Vaccine 17 Suppl:S105-108.
22. Sztajnbok, J., M. Lovgren, M.C. Brandileone, P.C. Marotto, J.A. Talbot and A.C. Seguro.
1999. Fatal group A streptococcal toxic shock-like syndrome in a child with varicella: report
of the first well documented case with detection of genetic sequences that code for exotoxins
spe A and B, in São Paulo, Brazil. Revista do Instituto de Medicina Tropical de São
Paulo;41:63-65.
21. Weiss K., M. Laverdiere, M. Lovgren, J. Delorme, L. Poirier and C. Beliveau. 1999. Group
A Streptococcus carriage among close contacts of patients with invasive infections.
American Journal of Epidemiology;149:863-868.
20. Zanella, R.C., R. Valdetaro, M. Lovgren, G.J. Tyrrell, S. Bokerman, S.C. Almeida, V.S.
Vieira, and M.C. Brandileone. 1999. First confirmed case of a vancomycin-resistant
Enterococcus faecium with vanA phenotype from Brazil: isolation from a meningitis case in
São Paulo. Microb Drug Resistance;5:159-162.
19. Lovgren, M., and J. A. Talbot. 1999. Antimicrobial-resistant Streptococcus pneumoniae.
Canadian Journal of Infectious Disease;9 suppl A:27A-29A.
18. Kertesz. D. A., L. Senzilet, M. Alagaratnam, M. Lovgren, J. A. Talbot, and J. S. Spika. 1999.
Invasive pneumococcal disease in Canada 1996: results from sentinel health unit
surveillance system. Canadian Journal of Infectious Disease;9 suppl A:22A-23A.
17. McGeer, A., K. Green, L. Landry, J. Talbot, E. Goldenberg, and the Toronto Invasive
Bacterial Diseases Network. 1999. Assessing the potential impact of vaccination programs
on invasive pneumococcal disease: data from population-based surveillance. Canadian
Journal of Infectious Disease;9 suppl A:24A-26A.
16. Casteñeda, E., Sistema Regional de Vacunas, Pan American Health Organization
Pneumococcal Study Group, National Centre for Streptococcus, and the Laboratory Centre
for Disease Control. 1999. Epidemiological surveillance study of Streptococcus pneumoniae
in Latin America: serotype distribution. A Pan American Health Organization initiative.
Canadian Journal of Infectious Disease;9 suppl A:41A-43A.
page 4 of 6
15. Lovgren, M., L. Dell’Acqua, R. Palacio, G. Echániz-Aviles, A. Soto-Noguerón, E.
Casteñeda, C. I. Agudela, I. Heitmann, M. C. Brandileone, R. C. Zanella, A. Rossi, J. Pace,
J. A Talbot, and the Pneumococcal Study Group. 1999. Determination of trimethoprimsufamethoxazole resistance in Streptococcus pneumoniae by using the E test with mueller
hinton agar supplemented with sheep or horse blood may be unreliable. Journal of Clinical
Microbiology;37:215-217.
14. Chagla, A. H., A. A. Borczyk, R. R. Facklam and M. Lovgren. 1998. Breast abscess
associated with Helcococcus kunzii. Journal of Clinical Microbiology;36:2377-2379.
13. Goh, S. H., D. Driedger, S. Gillet, D. E. Low, S. M. Hemmingsen, M. Amos, D. Chan, M.
Lovgren, B. M. Willey, C. Shaw, and J. A. Smith. 1998. Streptococcus iniae, a human and
animal pathogen: specific identification by the chaperonin 60 gene identification method.
Journal of Clinical Microbiology;36:2164-2166.
12. Kertesz, D. A., J. L. Di Fabio, M. C. de Cunto Brandileone, E. Casteñeda, G. Echániz-Aviles,
I. Heitmann, A. Homma, M. Hortal, M. Lovgren, R. O. Ruvinsky, J. A. Talbot, J. Weekes, J.
S. Spika, and the PAHO Pneumococcal Surveillance Study Group. 1998. Invasive
Streptococcus pneumoniae infection in Latin American children: results of the Pan
American Health Organization surveillance study. Clinical Infectious Disease;26:13551361.
11. Cockerill, F. R., R. L. Thompson, J. M. Musser, P. M. Schlievert, J. Talbot, K. E. Holley, W.
S. Harmsen, D. M. Ilstrup, P. C. Kohner, M. H. Kim, B. Frankfort, J. M. Manahan, J. M.
Steckelberg, F. Robertson, and W. R. Wilson and the Southeastern Minnesota Streptococcal
Working Group. 1998. Molecular, serological, and clinical features of 16 consecutive cases
of invasive streptococcal disease. Clinical Infectious Disease;26:1448-1458.
10. Spika, J. S., D. Kertesz, S. Deekes and J. Talbot. 1998. Pneumococcal infection and antipneumococcal vaccination programs in Canada. Presse Medicale;27 Suppl 1:39-42.
9. Kellner, J. D., A. McGeer, M. S. Cetron, D. E. Low, J.C. Butler, A. Matlow, J. Talbot, and E.
L. Ford-Jones. 1998. The use of Streptococcus pneumoniae nasopharyngeal isolates from
healthy children to predict features of invasive disease. Pediatric Infectious Disease
Journal;17:279-286.
8. Lovgren, M., J. S. Spika and J. A. Talbot. 1998. Invasive Streptococcus pneumoniae
infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.
Canandian Medical Association Journal;158:327-331.
7. Rusen, I.D., L. Fraser-Roberts, L. Slaney, J. Ombette, M. Lovgren, P. Datta, J. NdinyaAchola, J. A. Talbot, N. Nagelkerke, F. A. Plummer and J. E. Embree. 1997.
Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance,
strain types and associations with human immunodeficiency virus type 1 infection. Pediatric
Infectious Disease Journal;16:656-662.
page 5 of 6
6. Forwick, B.A., M. Lovgren, L. Chui and J. A. Talbot. 1997. Distribution of group A serotypes
and streptococcal pyrogenic exotoxin gene types isolated from blood in Canada. Advances
in Experimental Medicine & Biology;418:237-239.
5. Cockerill, F. R. III, K. L. MacDonald, R. L. Thompson, F. Roberson, P. C. Kohner, J. BesserWiek, J. M. Manahan, J. M. Musser, P. Schlievert, J. Talbot, J. M. Steckelberg, W. R.
Wilson, the Southwestern Minnesota Streptococcal Working Group and M. T. Osterholm.
1997. An outbreak of invasive group A streptococcal disease associated with high carriage
rates of the invasive clone among school-aged children. JAMA;277:38-43.
4. Davies, H. D., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, D. E. Low, and the
Ontario Group A Streptococcal Study Group. 1996. Invasive group A streptococcal
infections in Ontario, Canada. New England Journal of Medicine;335:547-554.
3. Weinstein, M., D.E. Low, A. McGeer, B. Willey, D. Rose, M. Coulter, P Wyper, A. Borczyk,
M. Lovgren and R. R. Facklam. 1996. Invasive Infection due to Streptococcus iniae: a new
or previously unrecognised disease - Ontario, 1995-1996. Canada Communicable Disease
Report;22:129-131.
2. Weinstein, M., D.E. Low, A. McGeer, B. Willey, D. Rose, M. Coulter, P Wyper, A. Borczyk,
M. Lovgren and R. R. Facklam. 1996. Invasive Infection with Streptococcus iniae Ontario, 1995-1996. Morbidity and Mortality Weekly Report;45:650-653.
1. Davies,H.D., A. Matlow, S.R. Scriver, P. Schleivert, M. Lovgren, J.A. Talbot and D.E. Low.
1994. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in
children with invasive Group A streptococcal infections compared with adults. Pediatric
Infectious Disease Journal;13:49-56.
page 6 of 6